A guest blog by Beate Kretschmer, Director Market Access at Lilly Germany
Latest estimates show that over 60 million Europeans live with diabetes. In Germany, this holds true for about 7.5 million people – with a rising tendency. As people are being diagnosed with diabetes at an increasingly younger age, in Germany alone, over 2 million patients with the chronic condition are of working age. This is why we are committed to improve the conditions for people living and working with diabetes.
Read more
With Brexit barely 15 months away, the UK government, as well as the European and British life science industry, is...
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.